Barrett's esophagus with high grade dysplasia: Surgical results and long-term outcome - An update

Journal of Gastrointestinal Surgery

Volumn 7, Issue 2, 2003, Pages 164-171

  Tseng, Elaine E ^a   Wu, T T ^a   Yeo, Charles J ^a   Heitmiller, Richard F ^b,c   Nandurkar, Sanjay ^c   Oleynikov, Dmitry ^c   Deschamps, Claude ^c   DeMeester, Thomas R ^c   Quijano Orvananos, Fernando ^c   Peters, Jeffrey H ^c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNION MEMORIAL HOSPITAL   (United States)

^c Johnson Professional Building ^*

Author keywords

Barrett's esophagus; Dysplasia

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; BIOPSY; CANCER STAGING; CONTROLLED STUDY; DEMOGRAPHY; DISEASE MARKER; DISEASE SEVERITY; DYSPLASIA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OCCULT CANCER; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; REVIEW; SURVIVAL; TREATMENT OUTCOME; ANASTOMOSIS; ARTICLE; CASE CONTROL STUDY; ESOPHAGUS TUMOR; INCIDENCE; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; NONPARAMETRIC TEST; PATHOLOGY; PRECANCER; PRIMARY PREVENTION; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; SURVIVAL RATE; TIME;

ADENOCARCINOMA; AGED; ANASTOMOSIS, SURGICAL; BARRETT ESOPHAGUS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PRIMARY PREVENTION; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037824715     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(02)00153-1     Document Type: Article

References (22)

1. Heitmiller R.F., Redmond M., Hamilton S.R. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy Ann Surg. 224:1996;66-71.
2. Hamilton S.T., Smith R.R.L. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol. 87:1987;301-312.
3. Hamilton S.R., Smith R.R.L. Epithelial dysplasia in Barrett esophagus. Relationship to invasive carcinoma Gastroenterology. 86:1984;1105.
4. DeMeester S.R., DeMeester T.R. Columnar mucosa and intestinal metaplasia of the esophagus. Fifty years of controversy Ann Surg. 231:2000;303-321.
5. Tygat G.N.J., Hameeteman W. The neoplastic potential of columnar-lined (Barrett's) esophagus. World J Surg. 16:1992;308-312.
6. Miros M., Kerlin P., Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's esophagus. Gut. 32:1991;1441-1446.
7. Hameeteman W., Tygat G.N.J., Houtoff H.J.et al. Barrett's esophagus. Development of dysplasia and adenocarcinoma Gastroenterology. 96:1989;1249-1256.
8. Weston A.P., Badr A.S., Hassanein R.S. Prospective multivariate analysis of clinical, endoscopic, and histologic factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol. 94:1999;3413-3419.
9. O'Connor J.B., Falk G.W., Richter J.E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus. Report on the Cleveland Clinic Barrett's Esophagus Registry Am J Gastroenterol. 94:1999;2037-2042.
10. Reid B.J., Haggitt R.C., Rubin C.E.et al. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adeocarcinoma Gastroenterolgy. 93:1987;1-11.
11. Reid B.J., Blount P.L., Rubin C.E.et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus. Prospective endoscopic surveillance of a cohort Gastroenterology. 102:1992;1212-1219.
12. Reid B.J., Levine G.S., Longton G.et al. Predictors of progression to cancer in Barrett's esophagus. Baseline histology and flow cytometry identify low- and high-risk patient subsets Am J Gastroenterol. 95:2000;1669-1676.
13. Ramel S., Reid B.J., Sanchez C.A.et al. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology. 102:1992;1220-1228.
14. Younes M., Lebovitz R.M., Lechago L.E.et al. p53 protein accumulation in Barrett's metaplasia, dysplasia and carcinoma. A follow-up study Gastroenterology. 105:1993;1637-1642.
15. Robertson C.S., Mayberry J.F., Nicholson D.A.et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's esophagus. Br J Surg. 75:1988;760-763.
16. Weston A.P., Sharma P., Topalovski M.et al. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol. 95:2000;1888-1893.
17. Schnell T.G., Sontag S.J., Chejfec G., Aranha G.et al. Long-term non-surgical management of Barrett's Esophagus with high-grade dysplasia. Gastroenterology. 120:2001;1607-1609.
18. Pellegrini C.A., Pohl D. High-grade dysplasia in Barrett's esophagus. Surveillance or operation? J Gastrointest Surg. 4:2000;131-134.
19. Cameron A.J., Carpenter H.A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma. a pathological study Am J Gastroenterol. 92:1997;586-591.
20. Pera M., Trasek V.F., Carpenter H.A.et al. Barrett's esophagus with high-grade dysplasia. An indication for esophagectomy? Ann Thor Surg. 54:1992;199-204.
21. Rice T.W., Falk G.W., Achkar E.et al. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol. 88:1993;1832-1836.
22. The Society for Surgery of the Alimentary Tract (SSAT), American Gastroenterological Association (AGA), American Society for Gastrointestinal Endoscopy (ASGE) Consensus Panel. Management of Barrett's esophagus. J Gastrointest Surg 2000;4:115-116.